Blasi F - Search Results

1

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.

Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Resnati M, et al. Among authors: blasi f. EMBO J. 1996 Apr 1;15(7):1572-82. EMBO J. 1996. PMID: 8612581 Free PMC article.

2

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):205-22. doi: 10.1023/a:1023099415940. Cancer Metastasis Rev. 2003. PMID: 12784997 Review.

3

Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.

Cunningham O, Andolfo A, Santovito ML, Iuzzolino L, Blasi F, Sidenius N. Cunningham O, et al. Among authors: blasi f. EMBO J. 2003 Nov 17;22(22):5994-6003. doi: 10.1093/emboj/cdg588. EMBO J. 2003. PMID: 14609946 Free PMC article.

4

Specific immunofluorimetric assay detecting the chemotactic epitope of the urokinase receptor (uPAR).

Resnati M, Pallavicini I, Daverio R, Sidenius N, Bonini P, Blasi F. Resnati M, et al. Among authors: blasi f. J Immunol Methods. 2006 Jan 20;308(1-2):192-202. doi: 10.1016/j.jim.2005.10.013. Epub 2005 Dec 19. J Immunol Methods. 2006. PMID: 16386755

5

The urokinase receptor: focused cell surface proteolysis, cell adhesion and signaling.

Blasi F, Sidenius N. Blasi F, et al. FEBS Lett. 2010 May 3;584(9):1923-30. doi: 10.1016/j.febslet.2009.12.039. Epub 2009 Dec 27. FEBS Lett. 2010. PMID: 20036661 Free article. Review.

6

Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?

Fazioli F, Blasi F. Fazioli F, et al. Among authors: blasi f. Trends Pharmacol Sci. 1994 Jan;15(1):25-9. doi: 10.1016/0165-6147(94)90130-9. Trends Pharmacol Sci. 1994. PMID: 8140655 Review.

7

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. Fazioli F, et al. Among authors: blasi f. EMBO J. 1997 Dec 15;16(24):7279-86. doi: 10.1093/emboj/16.24.7279. EMBO J. 1997. PMID: 9405357 Free PMC article.

8

Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells.

Degryse B, Resnati M, Rabbani SA, Villa A, Fazioli F, Blasi F. Degryse B, et al. Among authors: blasi f. Blood. 1999 Jul 15;94(2):649-62. Blood. 1999. PMID: 10397732 Free article.

9

Structure and function of the urokinase receptor.

Mondino A, Resnati M, Blasi F. Mondino A, et al. Among authors: blasi f. Thromb Haemost. 1999 Sep;82 Suppl 1:19-22. Thromb Haemost. 1999. PMID: 10695480 Review.

10

Domain 1 of the urokinase receptor (uPAR) is required for uPAR-mediated cell binding to vitronectin.

Sidenius N, Blasi F. Sidenius N, et al. Among authors: blasi f. FEBS Lett. 2000 Mar 17;470(1):40-6. doi: 10.1016/s0014-5793(00)01282-5. FEBS Lett. 2000. PMID: 10722842 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,169 results

Search Page

Filters